SCHEMBL3328361

SCHEMBL3328361

C/C=C/C(=O)c1ccc2c(c1)Cc1cc(C(=O)/C=C/C)ccc1S2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 6/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ NPC1 O15118 2/20 0.39
▸ THRB P10828 2/20 0.38
▸ THRA P10827 1/20 0.38
▸ MITF O75030 1/20 0.36
▸ HSP90AA1 P07900 1/20 0.36
▸ ALDH1A1 P00352 4/20 0.35
▸ LMNA P02545 4/20 0.35
▸ HTT P42858 3/20 0.35
▸ NPSR1 Q6W5P4 3/20 0.35
▸ PKM P14618 2/20 0.35
▸ ATM Q13315 2/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ HPGD P15428 2/20 0.35
▸ NLRP1 Q9C000 1/20 0.35
▸ NTSR1 P30989 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3328363 1.00 MAPT (0.39) MAPTRAB9ANPC1THRBTHRA
SCHEMBL31274105 0.73 ALDH1A1 (0.53) MAPTRAB9ANPC1THRBTHRA
SCHEMBL3008104 0.73 GAA (0.49) MAPTRAB9ANPC1ALDH1A1LMNA
SCHEMBL11822361 0.72 LMNA (0.42) MAPTRAB9ANPC1ALDH1A1LMNA
SCHEMBL11822375 0.72 LMNA (0.42) MAPTRAB9ANPC1ALDH1A1LMNA
SCHEMBL27791546 0.70 ALDH1A1 (0.49) MAPTRAB9ANPC1ALDH1A1LMNA
SCHEMBL11813095 0.70 GSK3B (0.44) MAPTRAB9ANPC1THRBTHRA
SCHEMBL11869377 0.70 KDM4E (0.45) MAPTRAB9ANPC1THRBTHRA
SCHEMBL15846800 0.69 SRD5A2 (0.58) MAPTALDH1A1LMNAHTTATM
SCHEMBL11730430 0.69 CTNNB1 (0.36) MAPTRAB9ANPC1ALDH1A1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2144900-B1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2015-03-18 — — EP disclosed
US-8524425-B2 Oxime ester photoinitiators BASF SE (DE) 2013-09-03 — — US disclosed
US-20100136467-A1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2010-06-03 — — US disclosed
EP-2144900-A1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2010-01-20 — — EP disclosed
WO-2008138732-A1 OXIME ESTER PHOTOINITIATORS BASF SE (CH) 2008-11-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100136467-A1 OXIME ESTER PHOTOINITIATORS CHRM4, NR2E3, CYP3A4 MAPT 3589/4885RAB9A 4835/4885NPC1 4059/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback